Mark R Blake - Net Worth and Insider Trading

Mark R Blake Net Worth

The estimated net worth of Mark R Blake is at least $2 Million dollars as of 2024-05-06. Mark R Blake is the EVP - Strategy & Corp. Dev. of Cardinal Health Inc and owns about 20,409 shares of Cardinal Health Inc (CAH) stock worth over $2 Million. Details can be seen in Mark R Blake's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark R Blake has not made any transactions after 2014-11-07 and currently still holds the listed stock(s).

Transaction Summary of Mark R Blake

To

Mark R Blake Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark R Blake owns 1 companies in total, including Cardinal Health Inc (CAH) .

Click here to see the complete history of Mark R Blake’s form 4 insider trades.

Insider Ownership Summary of Mark R Blake

Ticker Comapny Transaction Date Type of Owner
CAH Cardinal Health Inc 2014-11-07 EVP - Strategy & Corp. Dev.

Mark R Blake Latest Holdings Summary

Mark R Blake currently owns a total of 1 stock. Mark R Blake owns 20,409 shares of Cardinal Health Inc (CAH) as of November 7, 2014, with a value of $2 Million.

Latest Holdings of Mark R Blake

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CAH Cardinal Health Inc 2014-11-07 20,409 98.91 2,018,654

Holding Weightings of Mark R Blake


Mark R Blake Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark R Blake has made a total of 0 transactions in Cardinal Health Inc (CAH) over the past 5 years. The most-recent trade in Cardinal Health Inc is the sale of 24,668 shares on November 7, 2014, which brought Mark R Blake around $2 Million.

Insider Trading History of Mark R Blake

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark R Blake Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark R Blake Ownership Network

Ownership Network List of Mark R Blake

No Data

Ownership Network Relation of Mark R Blake


Mark R Blake Owned Company Details

What does Cardinal Health Inc do?

Who are the key executives at Cardinal Health Inc?

Mark R Blake is the EVP - Strategy & Corp. Dev. of Cardinal Health Inc. Other key executives at Cardinal Health Inc include CEO & Pharmaceutical Segment Deborah Weitzman , Chief Accounting Officer Mary C. Scherer , and CEO & Medical Segment Stephen M Mason .

Cardinal Health Inc (CAH) Insider Trades Summary

Over the past 18 months, Mark R Blake made no insider transaction in Cardinal Health Inc (CAH). Other recent insider transactions involving Cardinal Health Inc (CAH) include a net sale of 98,716 shares made by Stephen M Mason , a net sale of 45,914 shares made by Ola M Snow , and a net sale of 43,354 shares made by Deborah Weitzman .

In summary, during the past 3 months, insiders sold 0 shares of Cardinal Health Inc (CAH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 251,492 shares of Cardinal Health Inc (CAH) were sold and 550 shares were bought by its insiders, resulting in a net sale of 250,942 shares.

Cardinal Health Inc (CAH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cardinal Health Inc Insider Transactions

No Available Data

Mark R Blake Mailing Address

Above is the net worth, insider trading, and ownership report for Mark R Blake. You might contact Mark R Blake via mailing address: 7000 Cardinal Place, Dublin Oh 43017.

Discussions on Mark R Blake

No discussions yet.